Embedded Files
Mitosis Bioscience News and Activities
Mitosis Bioscience News and Activities
Go-To-Market strategy, building sales funnels that convert, lead generation, cold outreach, and closing B2B deals Hosted by CNAI Accelerator Cambodia with Katrin Kiviselg
Global Insights, Local Impact!
Back on 12th August 2025, Mitosis Bioscience's founder, Dr. Tam, joined a gathering of CNAI Accelerator Cambodia #3 Top 20 companies for a powerful training day with Katrin Kiviselg, delivered through Swisscontact’s EiR Initiative of the Enhancing Entrepreneurial Ecosystem and Investments (3Ei) program, co-financed by the Swiss Agency for Development and Cooperation (SDC), the Korea International Cooperation Agency (KOICA), and Khmer Enterprise (KE).
Katrin brought her global expertise from working with top startups like Bolt and MeetFrank, guiding founders on Go-To-Market strategy, building sales funnels that convert, lead generation, cold outreach, and closing B2B deals. The session was packed with roleplays, practical tools, and actionable insights, equipping our founders with a repeatable sales process to scale faster.
Thank you to Swisscontact and Katrin for this impactful session for Cnai Cohort. We can’t wait to see how our founders put these lessons into action in the months ahead!
#Cnai #StartupSupport #Entrepreneurship #GoToMarket #B2BSales #Swisscontact #CambodiaStartups #mitosis #vaccineincambodia #vaccinecompany
Mitosis Bioscience “Life Above All, Science in Every Dose.”
Mitosis Bioscience “Life Above All, Science in Every Dose.”
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
Building strong sales foundations to mastering B2B & B2C approaches, pricing strategies, and digital lead generation by Mr. Roswell Thomas
On July 29th 2025, Dr Tam, a representative of Mitosis Bioscience, joined a Sales, Business Development & Growth Training for Cambodian SMEs at Khmer Enterprise (KE), Angkor Wat Room, hosted by CNAI Accelerator Cambodia.
From building strong sales foundations to mastering B2B & B2C approaches, pricing strategies, and digital lead generation, the session equipped founders with practical, contextual tools to strengthen their sales capabilities in the Cambodian market.
A big thank you to Mr. Roswell Thomas for leading such an insightful and hands-on training, and to all our passionate SGB teams for their active participation.
#SMEs #startup #Cambodia #SalesTraining #entrepreneurship #CnaiAccelerator #cnai #mitosis #vaccineincambodia #vaccinecompany
Mitosis Bioscience “Life Above All, Science in Every Dose.”
Mitosis Bioscience “Life Above All, Science in Every Dose.”
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
Partnership Strategy, Value-based pricing, and Business Advice by Bong Keo Sar
June 26th, 2025 The Mitosis Bioscience team was so excited to join the training of CNAI Accelerator Cambodia conducted by Bong Keo Sar, a Khmer American Entrepreneur in Resident, held through Swisscontact’s EiR Initiative of the Enhancing Entrepreneurial Ecosystem and Investments (3Ei) program. This initiative is co-financed by the Swiss Agency for Development and Cooperation (SDC), the Korea International Cooperation Agency (KOICA), and សហគ្រិនខ្មែរ Khmer Enterprise (KE).
Bong Keo shared valuable insights on partnership strategy, value-based pricing, and business advice - equipping Cnai founders with practical tools for growth.
Big thanks to Swisscontact and Bong Keo for this impactful session! We look forward to more collaborations like this in the future.
#cnai #StartupSupport #entrepreneurlife #ValueBasedPricing #partnershipstrategy #Swisscontact #cambodiastartup #CnaiAccelerator #mitosis #vaccineincambodia #vaccinecompany
Mitosis Bioscience “Life Above All, Science in Every Dose.”
Mitosis Bioscience “Life Above All, Science in Every Dose.”
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
Mitosis Bioscience and its co-founders graduated from Cnai Accelerator Cohort 3, The Top 20 Companies in 2025
Message from CNAI Accelerator Cambodia
Cnai Accelerator Cohort 3 | Field Visits to the Top 20 Companies
As part of our commitment to supporting startups, we recently visited the Top 20 Cnai Accelerator companies, gaining firsthand insights into their operations, challenges, and ambitions.
These visits allowed us to engage directly with founders, understand their business journeys, and explore ways to support their growth. It’s inspiring to see their dedication and resilience in building impactful ventures.
Thank you to all the teams for your warm welcome and for sharing your journey with us. We’re excited to continue this journey together!
#CambodiaAccelerator #CnaiAccelerator #Cambodia #Entrepreneurship #Startups #StartupFounder #mitosis #vaccineincambodia #vaccinecompany
Mitosis Bioscience “Life Above All, Science in Every Dose.”
Mitosis Bioscience “Life Above All, Science in Every Dose.”
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
Strengthening Japan–Cambodia Vaccine Collaboration: Mitosis Bioscience Visits KM Biologics
Strengthening Japan–Cambodia Vaccine Collaboration: Mitosis Bioscience Visits KM Biologics
Kumamoto, Japan – January 2025 – Under the support of JICA, the Cambodia–Japan Accelerator Program (CJAP), and Deloitte Tohmatsu Japan, Dr. Nov Tam, representing the founding team of Mitosis Bioscience Co., Ltd., paid an official visit to KM Biologics (KMB), a subsidiary of Meiji Group and one of Japan’s most respected vaccine manufacturers.
The purpose of the visit was to establish a strategic connection between Mitosis Bioscience and KMB, opening the path toward potential vaccine supply and collaboration to improve access to high-quality vaccines in Cambodia.
KM Biologics: A Trusted Partner in Japan’s Public Health
KM Biologics: A Trusted Partner in Japan’s Public Health
KMB is a leading Japanese vaccine manufacturer with a strong legacy of supplying safe and effective vaccines to the Government of Japan for the protection of its population. With a broad portfolio covering multiple infectious diseases, KMB continues to play a central role in Japan’s national immunization strategy.
During the visit, Dr. Tam was welcomed by KMB’s production management team and toured one of the company’s state-of-the-art manufacturing facilities. The visit provided first-hand exposure to cutting-edge production technology and internationally recognized quality standards, reinforcing KMB’s reputation as a global leader in vaccine innovation and reliability.
Exploring Opportunities for Cambodia
Exploring Opportunities for Cambodia
In bilateral discussions, Mitosis Bioscience and KMB explored proposals for introducing KMB’s vaccine portfolio to Cambodia, aiming to protect Cambodian children and families from preventable infectious diseases. Several potential areas of collaboration were identified, including:
Direct supply of vaccines to Cambodia through Mitosis Bioscience.
Joint efforts in knowledge transfer and quality assurance, aligning with Cambodia’s regulatory framework.
Long-term collaboration opportunities for strengthening vaccine access and cold-chain management in Cambodia.
Shared Commitment to Public Health
The meeting concluded in a positive and forward-looking atmosphere, with both companies expressing strong interest in building a foundation for long-term cooperation. Mitosis Bioscience reaffirmed its mission to bring trusted, science-based, and high-quality vaccines to the Cambodian market, while KMB welcomed the opportunity to contribute its expertise and innovation toward protecting public health in Cambodia.
About Mitosis Bioscience Co., Ltd.
Mitosis Bioscience is a Cambodian-owned biopharmaceutical company dedicated to improving public health through the import, distribution, and future local production of innovative vaccines and biologics. Founded in 2022 by a team of physicians and entrepreneurs with more than two decades of combined experience, Mitosis is committed to ensuring life above all, quality vaccines, science-based evidence, and accessibility for every Cambodian.
#mitosis #vaccineincambodia #vaccinecompany
Mitosis Bioscience “Life Above All, Science in Every Dose.”
Mitosis Bioscience “Life Above All, Science in Every Dose.”
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
Courtesy Meeting Between MITOSIS BIOSCIENCE and NOMURA JIMUSHO, INC.
Tokyo, Japan– On January 23, 2025, Dr. Tam, representing the Mitosis Bioscience Co-founding team, met with Mr. Shoji Nomura, President of Nomura Jimusho, Inc., to explore potential business opportunities between the two companies. The productive and cordial meeting marks a significant milestone for Mitosis Bioscience as the first Cambodian company to establish a connection with Nomura Jimusho, a well-established player in the Japanese business community.
During the meeting, various topics were discussed, ranging from the business activities of Nomura Jimusho to the strategic goals of Mitosis Bioscience. One of the key points of discussion was Mitosis Bioscience’s ambition to collaborate with Nomura Jimusho in its efforts to secure the rights to distribute Takeda’s vaccine, specifically Qdenga, in Cambodia. As an endemic country facing the challenges of Dengue fever, Cambodia stands to benefit significantly from the introduction of this vaccine, which could help protect the population from the disease.
In addition to the potential vaccine collaboration, Dr. Tam expressed his hopes for Nomura Jimusho’s support in advancing Mitosis Bioscience’s broader business objectives. The company aims to continue building international partnerships that could drive the growth of its life sciences and healthcare initiatives, particularly in Southeast Asia.
Mitosis Bioscience also expressed its sincere gratitude for the support received from notable organizations, including JICA (Japan International Cooperation Agency), CJCC (Cambodia-Japan Cooperation Center), Deloitte Japan, and Professor Yukihisa Namiki. Their presence and backing added considerable value to the meeting, highlighting the strong network of collaborators that Mitosis has already begun to foster.
The meeting was regarded as highly productive, with both parties expressing optimism for future collaboration. It concluded on a positive note, with Dr. Tam thanking Mr. Nomura for his warm hospitality and keen interest in exploring ways to work together. Both sides agreed that the discussions would be the first step toward a long-term and mutually beneficial partnership.
With the potential for groundbreaking advancements in healthcare, particularly in the realm of infectious disease prevention, the collaboration between Mitosis Bioscience and Nomura Jimusho could pave the way for significant strides in improving public health in Cambodia and beyond.
#mitosis #vaccineincambodia #vaccinecompany
Mitosis Bioscience “Life Above All, Science in Every Dose.”
Mitosis Bioscience “Life Above All, Science in Every Dose.”
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
Strengthening Regional Ties: Mitosis Bioscience Meets with Sinovac Biotech
Strengthening Regional Ties: Mitosis Bioscience Meets with Sinovac Biotech
Phnom Penh – Jakarta – Beijing, December 4, 2024 – Mitosis Bioscience Co., Ltd. held an important online meeting with regional representatives of Sinovac Biotech,(Nasdaq: SVA), a leading global vaccine manufacturer.
The meeting, conducted via Zoom, brought together Mr. Jonas and Ms. Xinge, Business Development Managers from Sinovac, and Dr. Tam and Dr. Elin, Co-Founders of Mitosis Bioscience.
The discussion focused on exploring opportunities for vaccine import and distribution in Cambodia, paving the way for a long-term partnership aimed at improving vaccine accessibility and strengthening Cambodia’s immunization landscape.
This meeting marks a significant step toward expanding collaboration between Sinovac and Mitosis Bioscience, reinforcing both companies’ shared commitment to advancing public health and protecting communities against preventable infectious diseases.
#mitosis #vaccineincambodia #vaccinecompany
Mitosis Bioscience “Life Above All, Science in Every Dose.”
Mitosis Bioscience “Life Above All, Science in Every Dose.”
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
August 9, 2024 Dr. Tam Attends Inauguration of New Khema Hospital TK Wing
Phnom Penh, Cambodia – On August 9, 2024, Dr. Tam, representing the Mitosis Bioscience Co-founding team, attended the inauguration of the new building wing at Khema Hospital TK. This event marks a significant milestone in enhancing healthcare infrastructure in Cambodia.
Dr. Tam expressed his appreciation for being part of this momentous occasion, highlighting the importance of such developments in improving healthcare standards in the region. "This new wing is a crucial step towards better healthcare for our community," said Dr. Tam.
The event, attended by various dignitaries and healthcare professionals, featured a tour of the state-of-the-art facilities, showcasing the latest medical technologies.
Mitosis Bioscience plan is committed to addressing vaccine availability gaps in Cambodia. Dr. Tam's presence at the inauguration underscores the company’s dedication to supporting initiatives that improve health outcomes.
Dr. Tam concluded with heartfelt wishes for the continued success of Khema Hospital TK. "We extend our warmest congratulations and look forward to future collaborations to advance healthcare in Cambodia."
#mitosis #vaccineincambodia #vaccinecompany #khemahospital #hospitalincambodia
Mitosis Bioscience “Life Above All, Science in Every Dose.”
Mitosis Bioscience “Life Above All, Science in Every Dose.”
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
Health Education Videos
Health Education Videos
Basic Vaccination Information in Cambodia
Basic Vaccination Information in Cambodia
by Dr. Nov Tam & Dr. Phon Elin as of October, 2024
Introduction
Introduction
Vaccination is one of the most effective ways to protect individuals and communities from infectious diseases. In Cambodia, the National Immunization Program (NIP) ensures that children, adolescents, and adults receive essential vaccines that save lives and prevent outbreaks. Beyond the basic schedule, some additional vaccines are recommended for certain groups based on age, health status, or risk of exposure.
Vaccines in Cambodia’s National Immunization Program
Vaccines in Cambodia’s National Immunization Program
The Cambodian Ministry of Health (MoH), through the NIP, provides free vaccines to protect children from life-threatening diseases. The main vaccines include:
• BCG – given at birth to protect against severe forms of tuberculosis.
• Hepatitis B – birth dose and subsequent doses for lifelong protection.
• DTP (Diphtheria, Tetanus, Pertussis) – protects against three serious childhood infections.
• Hib (Haemophilus influenzae type b) – prevents meningitis and pneumonia.
• Polio (OPV/IPV) – part of the global effort to eradicate poliomyelitis.
• Measles and Rubella (MR or MMR) – given in early childhood with national campaigns to close immunity gaps.
• HPV (Human Papillomavirus) – introduced in October 2023, one dose for 9-year-old girls to prevent cervical cancer.
These vaccines are provided at health centers nationwide, ensuring that every child has access to protection from common and preventable diseases.
Additional Recommended Vaccines
Additional Recommended Vaccines
While the NIP covers the essential vaccines, additional vaccines are often advised depending on age, lifestyle, or health risk:
• COVID-19 Vaccine – recommended for adults, older persons, and those with chronic diseases to reduce severe illness and hospitalization.
• Influenza Vaccine – annual shot for older adults, healthcare workers, and people with chronic conditions.
• Hepatitis A Vaccine – important for travelers, food handlers, and people without prior immunity.
• Typhoid Vaccine – recommended for those living in or visiting areas with poor sanitation.
• Japanese Encephalitis Vaccine – strongly recommended for people in rural and agricultural areas where mosquitoes transmit the virus.
• Pneumococcal Vaccine – protects infants, the elderly, and those with weakened immune systems from pneumonia and meningitis.
• Tetanus and Diphtheria Boosters – needed every 10 years throughout life.
Life-Course Approach to Immunization
Life-Course Approach to Immunization
Cambodia’s National Immunization Strategy 2021–2025 highlights the importance of protecting health at every stage of life. This includes:
- Strengthening childhood immunization,
- Introducing adolescent vaccines such as HPV,
- Expanding adult vaccination programs, especially for influenza, COVID-19, and tetanus boosters.
This life-course approach ensures that prevention is not limited to childhood but continues across a person’s lifespan.
Conclusion
Conclusion
Vaccines remain the safest and most cost-effective public health tool in Cambodia. Families are encouraged to follow the national immunization schedule and consult healthcare providers about additional vaccines based on age, travel, and medical conditions. By maintaining high vaccination coverage, Cambodia continues to protect its population and move toward eliminating vaccine-preventable diseases.
References
References
1. Ministry of Health, Cambodia. National Immunization Strategy 2021–2025. Phnom Penh: NIP/MoH. https://nmchc.gov.kh/wp-content/uploads/2024/12/Final-NIS-CAM-National-Immunization-Strategy-2021-2025.pdf
2. UNICEF Cambodia. Life-saving HPV vaccine introduced nationwide into routine immunization schedule to prevent cervical cancer. 2023. https://www.unicef.org/cambodia/press-releases/life-saving-hpv-vaccine-introduced-nationwide-routine-immunization-schedule-prevent
3. National Maternal and Child Health Center (NMCHC). National Immunization Programme (NIP). https://nmchc.gov.kh/en/training/national-immunization-programme-nip/
4. DevelopmentAid. Cambodia to launch a measles and rubella vaccination campaign. 2024. https://www.developmentaid.org/news-stream/post/187124/cambodia-measles-rubella-vaccination
5. Centers for Disease Control and Prevention (CDC). Cambodia: Traveler View. https://wwwnc.cdc.gov/travel/destinations/traveler/none/Cambodia
6. World Health Organization (WHO). COVID-19 vaccination in Cambodia. WHO Regional Office for the Western Pacific. https://www.who.int/cambodia
7. PubMed Central. COVID-19 vaccination in Cambodia: successes and challenges. https://pmc.ncbi.nlm.nih.gov/articles/PMC10130549/
Mitosis Bioscience “Life Above All, Science in Every Dose.”
Mitosis Bioscience “Life Above All, Science in Every Dose.”
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
A biopharmaceutical company in Cambodia dedicated to protecting lives by delivering safe, high-quality, science-based vaccines with improved accessibility.
Google Sites
Report abuse